While FAP is highly expressed in fibroblasts within fibrotic lesions and tumors, its reduced levels in aggressive lymphoid malignancies suggest it may reflect a systemic reaction to the tumor rather than being tumor-derived [2,8,21]. This evidence concerns the gene FAP and neoplasm.